Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and regular brain scans, among others.
from Business News https://ift.tt/TaEQP80
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 09, 2024
0
